Enveric Biosciences (ENVB) announced the relocation of its corporate headquarters to Cambridge, Massachusetts, 02142. Enveric believes the move will foster stronger collaborations, facilitate top-tier talent recruitment, and enhance visibility within one of the world’s most vibrant life sciences clusters where world-class scientific expertise, leading biopharma companies, premier academic institutions, and a dynamic investor community converge.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB:
- Enveric Biosciences Releases New Investor Presentation
- Enveric Biosciences Receives Nasdaq Deficiency Letter
- Enveric Biosciences completes EB-003 dose range finding toxicology studies
- Psychedelic: atai Life Sciences, Cybin report earnings results
- Psychedelic: Clearmind completes site initiation for CMND-100 trial